Determination of liver-specific r2* of a highly monodisperse USPIO by 59Fe iron core-labeling in mice at 3 T MRI

Contrast Media and Molecular Imaging

Volumn 10, Issue 2, 2015, Pages 153-162

  Raabe, Nina ^a   Forberich, Evelyn ^a   Freund, Barbara ^a   Bruns, Oliver T ^b   Heine, Markus ^a   Kaul, Michael G ^a   Tromsdorf, Ulrich ^c   Herich, Lena ^a   Nielsen, Peter ^a   Reimer, Rudolph ^b   Hohenberg, Heinrich ^a   Weller, Horst ^c   Schumacher, U ^a   Adam, Gerhard ^a   Ittrich, Harald ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

3T MRI; Animal study; Quantification; Relaxometry; USPIO

Indexed keywords

IRON 59; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; CONTRAST MEDIUM; FERRIC ION; FERRIC OXIDE; IRON; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOLOGY; ISOTOPE LABELING; LIVER; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOACTIVITY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; ANIMAL; CHEMISTRY; DOSE RESPONSE; METABOLISM; PROCEDURES; RADIOGRAPHY; SCID MOUSE;

ANIMALS; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRIC COMPOUNDS; IRON ISOTOPES; ISOTOPE LABELING; LIVER; MAGNETIC RESONANCE IMAGING; MICE; MICE, SCID; NANOPARTICLES;

EID: 84927577791     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1612     Document Type: Article

References (46)

1. Saini S, Stark DD, Hahn PF, Bousquet JC, Introcasso J, Wittenberg J, Brady TJ, Ferrucci JT, Jr. Ferrite particles: a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma. Radiology 1987; 162(1 Pt 1): 217-222.
2. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994; 32(6): 749-763.
3. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med 2002; 48(1): 52-61.
4. Schnorr J, Wagner S, Abramjuk C, Drees R, Schink T, Schellenberger EA, Pilgrimm H, Hamm B, Taupitz M. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits. Radiology 2006; 240(1): 90-100.
5. Bremer C, Allkemper T, Baermig J, Reimer P. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography. J Magn Reson Imag 1999; 10(3): 461-467.
6. Montet X, Weissleder R, Josephson L. Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. Bioconjug Chem 2006; 17(4): 905-911.
7. Kinoshita M, Yoshioka Y, Okita Y, Hashimoto N, Yoshimine T. MR molecular imaging of HER-2 in a murine tumor xenograft by SPIO labeling of anti-HER-2 affibody. Contrast Media Mol Imag 2010; 5(1): 18-22.
8. Serkova NJ, Renner B, Larsen BA, Stoldt CR, Hasebroock KM, Bradshaw-Pierce EL, Holers VM, Thurman JM. Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice. Radiology 2010; 255(2): 517-526.
9. Kaim AH, Wischer T, O'Reilly T, Jundt G, Frohlich J, von Schulthess GK, Allegrini PR. MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats. Radiology 2002; 225(3): 808-814.
10. Priest AN, Ittrich H, Jahntz CL, Kooijman H, Weber C, Adam G. Investigation of atherosclerotic plaques with MRI at 3 T using ultrasmall superparamagnetic particles of iron oxide. Magn Reson Imag 2006; 24(10): 1287-1293.
11. Kawahara I, Nakamoto M, Kitagawa N, Tsutsumi K, Nagata I, Morikawa M, Hayashi T. Potential of magnetic resonance plaque imaging using superparamagnetic particles of iron oxide for the detection of carotid plaque. Neurol Med Chir (Tokyo) 2008; 48(4): 157-161; discussion 161-162.
12. Bos C, Delmas Y, Desmouliere A, Solanilla A, Hauger O, Grosset C, Dubus I, Ivanovic Z, Rosenbaum J, Charbord P, Combe C, Bulte JW, Moonen CT, Ripoche J, Grenier N. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology 2004; 233(3): 781-789.
13. Ittrich H, Lange C, Togel F, Zander AR, Dahnke H, Westenfelder C, Adam G, Nolte-Ernsting C. In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3T. J Magn Reson Imag 2007; 25(6): 1179-1191.
14. Shapiro EM, Medford-Davis LN, Fahmy TM, Dunbar CE, Koretsky AP. Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs) allows single cell detection by MRI. Contrast Media Mol Imag 2007; 2(3): 147-153.
15. Bruns OT, Ittrich H, Peldschus K, Kaul MG, Tromsdorf UI, Lauterwasser J, Nikolic MS, Mollwitz B, Merkel M, Bigall NC, Sapra S, Reimer R, Hohenberg H, Weller H, Eychmuller A, Adam G, Beisiegel U, Heeren J. Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals. Nat Nanotechnol 2009; 4(3): 193-201.
16. Liu W, Dahnke H, Rahmer J, Jordan EK, Frank JA. Ultrashort T2* relaxometry for quantitation of highly concentrated superparamagnetic iron oxide (SPIO) nanoparticle labeled cells. Magn Reson Med 2009; 61(4): 761-766.
17. Chung YE, Park MS, Kim MS, Kim E, Park J, Song HT, Choi JY, Kim MJ, Kim KW. Quantification of superparamagnetic iron oxide-mediated signal intensity change in patients with liver cirrhosis using T2 and T2* mapping: a preliminary report. J Magn Reson Imag 2010; 31(6): 1379-1386.
18. Langley J, Zhao Q. Quantification of SPIO nanoparticles using phase gradient mapping. Conf Proc IEEE Eng Med Biol Soc 2009; 2009: 3605-3608.
19. Pintaske J, Helms G, Bantleon R, Kehlbach R, Wiskirchen J, Claussen CD, Schick F. A preparation technique for quantitative investigation of SPIO-containing solutions and SPIO-labelled cells by MRI. Biomed Tech (Berl) 2005; 50(6): 174-180.
20. Lebel RM, Menon RS, Bowen CV. Relaxometry model of strong dipolar perturbers for balanced-SSFP: application to quantification of SPIO loaded cells. Magn Reson Med 2006; 55(3): 583-591.
21. Dahnke H, Schaeffter T. Limits of detection of SPIO at 3.0 T using T2 relaxometry. Magn Reson Med 2005; 53(5): 1202-1206.
22. Wong RM, Gilbert DA, Liu K, Louie AY. Rapid size-controlled synthesis of dextran-coated, 64Cu-doped iron oxide nanoparticles. ACS Nano 2012; 6(4): 3461-3467.
23. Freund B, Tromsdorf UI, Bruns OT, Heine M, Giemsa A, Bartelt A, Salmen SC, Raabe N, Heeren J, Ittrich H, Reimer R, Hohenberg H, Schumacher U, Weller H, Nielsen P. A simple and widely applicable method to 59Fe-radiolabel monodisperse superparamagnetic iron oxide nanoparticles for in vivo quantification studies. ACS Nano 2012; 6(8): 7318-7325.
24. Gibson N, Holzwarth U, Abbas K, Simonelli F, Kozempel J, Cydzik I, Cotogno G, Bulgheroni A, Gilliland D, Ponti J, Franchini F, Marmorato P, Stamm H, Kreyling W, Wenk A, Semmler-Behnke M, Buono S, Maciocco L, Burgio N. Radiolabelling of engineered nanoparticles for in vitro and in vivo tracing applications using cyclotron accelerators. Arch Toxicol 2011; 85(7): 751-773.
25. Natarajan A, Gruettner C, Ivkov R, DeNardo GL, Mirick G, Yuan A, Foreman A, DeNardo SJ. NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics. Bioconjug Chem 2008; 19(6): 1211-1218.
26. Glaus C, Rossin R, Welch MJ, Bao G. In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. Bioconjug Chem 2010; 21(4): 715-722.
27. Ittrich H, Lange C, Dahnke H, Zander AR, Adam G, Nolte-Ernsting C. [Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T]. Rofo 2005; 177(8): 1151-1163.
28. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Bulte JW, Frank JA. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation 2003; 76(7): 1123-1130.
29. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003; 229(3): 838-846.
30. Otsuji E, Kuriu Y, Okamoto K, Ichikawa D, Hagiwara A, Ito H, Nishimura T, Yamagishi H. Monoclonal antibody A7 coupled to magnetic particles as a contrast enhancing agent for magnetic resonance imaging of human colorectal carcinoma. Cancer Immunol Immunother 2006; 55(6): 728-733.
31. Himes N, Min JY, Lee R, Brown C, Shea J, Huang X, Xiao YF, Morgan JP, Burstein D, Oettgen P. In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction. Magn Reson Med 2004; 52(5): 1214-1219.
32. Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JW. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003; 107(18): 2290-2293.
33. Daldrup-Link HE, Rudelius M, Piontek G, Metz S, Brauer R, Debus G, Corot C, Schlegel J, Link TM, Peschel C, Rummeny EJ, Oostendorp RA. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology 2005; 234(1): 197-205.
34. Na HB, Song IC, Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater 2009; 21(21): 2133-2148.
35. Laurent S, Boutry S, Mahieu I, Vander Elst L, Muller RN. Iron oxide based MR contrast agents: from chemistry to cell labeling. Curr Med Chem 2009; 16(35): 4712-4727.
36. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989; 152(1): 167-173.
37. Hamm B, Staks T, Taupitz M, Maibauer R, Speidel A, Huppertz A, Frenzel T, Lawaczeck R, Wolf KJ, Lange L. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. J Magn Reson Imag 1994; 4(5): 659-668.
38. Bourrinet P, Bengele HH, Bonnemain B, Dencausse A, Idee JM, Jacobs PM, Lewis JM. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol 2006; 41(3): 313-324.
39. Thorek DL, Tsourkas A. Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 2008; 29(26): 3583-3590.
40. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990; 175(2): 489-493.
41. Tromsdorf UI, Bigall NC, Kaul MG, Bruns OT, Nikolic MS, Mollwitz B, Sperling RA, Reimer R, Hohenberg H, Parak WJ, Forster S, Beisiegel U, Adam G, Weller H. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. Nano Lett 2007; 7(8): 2422-2427.
42. Kuhlpeter R, Dahnke H, Matuszewski L, Persigehl T, von Wallbrunn A, Allkemper T, Heindel WL, Schaeffter T, Bremer C. R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing. Radiology 2007; 245(2): 449-457.
43. Girard OM, Ramirez R, McCarty S, Mattrey RF. Toward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRI. Contrast Media Mol Imag 2012; 7(4): 411-417.
44. Hyeon T, Lee SS, Park J, Chung Y, Na HB. Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J Am Chem Soc 2001; 123(51): 12798-12801.
45. Braunsfurth JS, Gabbe EE, Heinrich HC. Performance parameters of the Hamburg 4 pi whole body radioactivity detector. Phys Med Biol 1977; 22(1): 1-17.
46. Jung CW, Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imag 1995; 13(5): 661-674.